TrinityPoint Wealth’s Medtronic MDT Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2024
Q4
$3.67M Buy
45,962
+2,199
+5% +$190K 0.52% 50
2024
Q3
$3.94M Buy
43,763
+64
+0.1% +$5.38K 0.57% 44
2024
Q2
$3.44M Buy
43,699
+4,193
+11% +$344K 0.54% 46
2024
Q1
$3.44M Buy
39,506
+1,112
+3% +$94.9K 0.57% 45
2023
Q4
$3.16M Sell
38,394
-15,346
-29% -$1.17M 0.57% 40
2023
Q3
$4.21M Buy
53,740
+279
+0.5% +$23.4K 0.84% 23
2023
Q2
$4.71M Buy
53,461
+5,068
+10% +$436K 0.92% 22
2023
Q1
$3.9M Buy
48,393
+17,042
+54% +$1.39M 0.84% 26
2022
Q4
$2.44M Sell
31,351
-3,301
-10% -$268K 0.55% 49
2022
Q3
$2.8M Buy
34,652
+15,181
+78% +$1.36M 0.64% 36
2022
Q2
$1.75M Buy
19,471
+312
+2% +$31.6K 0.39% 66
2022
Q1
$2.13M Sell
19,159
-3,802
-17% -$402K 0.39% 62
2021
Q4
$2.38M Sell
22,961
-586
-2% -$67.9K 0.42% 59
2021
Q3
$2.95M Buy
23,547
+194
+0.8% +$25.1K 0.56% 50
2021
Q2
$2.9M Buy
23,353
+692
+3% +$86.9K 0.59% 48
2021
Q1
$2.68M Sell
22,661
-3
-0% -$352 0.62% 45
2020
Q4
$2.65M Sell
22,664
-285
-1% -$31.4K 0.64% 46
2020
Q3
$2.38M Buy
22,949
+726
+3% +$72.9K 0.66% 42
2020
Q2
$2.04M Buy
22,223
+1,378
+7% +$132K 0.64% 41
2020
Q1
$1.88M Buy
20,845
+359
+2% +$38.2K 0.74% 34
2019
Q4
$2.32M Sell
20,486
-462
-2% -$50.7K 0.78% 31
2019
Q3
$2.25M Buy
20,948
+39
+0.2% +$4.07K 0.78% 32
2019
Q2
$2.14M Sell
20,909
-925
-4% -$84.5K 1.03% 25
2019
Q1
$1.99M Buy
21,834
+1,828
+9% +$164K 0.98% 24
2018
Q4
$1.82M Buy
+20,006
New +$1.87M 1.12% 20

Other funds holding MDT

TrinityPoint Wealth's MDT Position: Q4 2024 in Review

TrinityPoint Wealth increased its Medtronic (MDT) stake by 5% in Q4 2024, buying an estimated $190K and bringing the position to 45,962 shares worth $3.67M. The position accounts for 0.52% of the portfolio, ranked #50.

TrinityPoint Wealth first reported a position in MDT in Q4 2018 and has held it in 25 quarters since. The position peaked at $4.71M in Q2 2023. 2,123 funds tracked by Wall St. Rank hold MDT as of Q4 2024.

  • TrinityPoint Wealth held 45,962 shares of Medtronic worth $3.67M as of Q4 2024.
  • TrinityPoint Wealth bought 2,199 Medtronic shares in Q4 2024, an estimated $190K.
  • Medtronic made up 0.52% of TrinityPoint Wealth's portfolio in Q4 2024, its #50 holding.
  • TrinityPoint Wealth first reported a position in Medtronic in Q4 2018 and has held it in 25 quarters since.
  • TrinityPoint Wealth's Medtronic position peaked at $4.71M in Q2 2023.
  • 2,123 funds tracked by Wall St. Rank held Medtronic as of Q4 2024.

Based on TrinityPoint Wealth's 13F filing for Q4 2024, filed 14 Feb 2025.